Concepedia

Sophie Beyer

SB

Statistics

Publications

15

Citations

1.1K

H-Index

13

Active since

1995

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Goethe University Frankfurt

Giessen School of Theology

Johannes Gutenberg University Mainz

Sophie Beyer is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, life sciences, and endothelin receptor antagonists.

Publications per year

1995–2020

15

Publications

15

The Histone Demethylases JMJD1A and JMJD2B Are Transcriptional Targets of Hypoxia-inducible Factor HIF

Sophie Beyer, Malene M. Kristensen, K.S. Jensen et al. · Journal of Biological Chemistry · 2008 · 340 citations · Full text

, , +17

Selective blockade of the endothelin subtype A receptor decreases early atherosclerosis in hamsters fed cholesterol.

Mark C. Kowala, Patricia M. Rose, Philip D. Stein et al. · PubMed · 1995 · 127 citations

, , +15

Dual Angiotensin II and Endothelin A Receptor Antagonists:  Synthesis of 2‘-Substituted N-3-Isoxazolyl Biphenylsulfonamides with Improved Potency and Pharmacokinetics

Natesan Murugesan, Zhengxiang Gu, Leena Fadnis et al. · Journal of Medicinal Chemistry · 2004 · 88 citations

, , +17

Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE

Mark C. Kowala, Ron Recce, Sophie Beyer et al. · Atherosclerosis · 2000 · 83 citations

, , +17

A modular DNA signal translator for the controlled release of a protein by an aptamer

Sophie Beyer · Nucleic Acids Research · 2006 · 76 citations · Full text

, , +13

1–5 of 15